Clinical Trials

NCT03816319 | RECRUITING | PHASE1
42 participants

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2025-03-12
Completion:
2026-10-24
Conditions
  • Myelodysplastic Syndrome With Excess Blasts
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Myelodysplastic Syndrome
  • Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Myelodysplastic Syndrome
  • Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT03203525 | TERMINATED | PHASE1
38 participants

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2020-06-23
Completion:
2026-07-22
Conditions
  • Advanced Malignant Neoplasm
  • Colorectal Carcinoma Metastatic in the Liver
  • Metastatic Malignant Neoplasm in the Liver
  • Refractory Malignant Neoplasm
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page